{"id":30828,"date":"2025-04-16T10:40:28","date_gmt":"2025-04-16T09:40:28","guid":{"rendered":"https:\/\/by-tv.co.uk\/?p=30828"},"modified":"2025-04-16T10:40:28","modified_gmt":"2025-04-16T09:40:28","slug":"kalp-yetmezliginini-%62-azaltan-erken-ilac-dozlari-ingilterede-kullanima-acildi","status":"publish","type":"post","link":"https:\/\/by-tv.co.uk\/en\/kalp-yetmezliginini-%2562-azaltan-erken-ilac-dozlari-ingilterede-kullanima-acildi\/","title":{"rendered":"Kalp Yetmezli\u011finini %62 Azaltan Erken \u0130la\u00e7 Dozlar\u0131 \u0130ngiltere’de Kullan\u0131ma A\u00e7\u0131ld\u0131"},"content":{"rendered":"

Birle\u015fik Krall\u0131k’ta baz\u0131 hastaneler, kalp yetmezli\u011fi tedavisinde \u00e7\u0131\u011f\u0131r a\u00e7an bir uygulamaya ge\u00e7ti. Bu yeni y\u00f6ntemde hastalara, tedavinin ilk haftalar\u0131nda daha y\u00fcksek dozda ila\u00e7 veriliyor. Uygulama, \u00f6l\u00fcmleri y\u00fczde 62 oran\u0131nda azaltmas\u0131 nedeniyle uzmanlar taraf\u0131ndan \u201coyun de\u011fi\u015ftirici\u201d olarak nitelendiriliyor.<\/p>\n

The Guardian\u2019\u0131n aktard\u0131\u011f\u0131na g\u00f6re, k\u00fcresel Strong-HF adl\u0131 klinik \u00e7al\u0131\u015fmadan elde edilen veriler, tedaviye y\u00fcksek dozla ba\u015flanmas\u0131n\u0131n hem \u00f6l\u00fcm riskini hem de tekrar hastaneye yat\u0131\u015f ihtimalini \u00f6nemli \u00f6l\u00e7\u00fcde azaltt\u0131\u011f\u0131n\u0131 g\u00f6sterdi. \u00c7al\u0131\u015fma, 14 \u00fclkede 87 hastanede uyguland\u0131 ve sonu\u00e7lar\u0131 umut verici bulundu.<\/p>\n

Yeni y\u00f6ntem: H\u0131zl\u0131 doz art\u0131r\u0131m\u0131<\/strong><\/h4>\n

“Rapid titration” (h\u0131zl\u0131 doz art\u0131r\u0131m\u0131) olarak bilinen y\u00f6ntemde, hastalara te\u015fhisten sonraki ilk iki hafta i\u00e7inde hedeflenen ila\u00e7 dozlar\u0131 veriliyor. \u00d6nceki uygulamada bu s\u00fcre\u00e7 9 ila 12 ay s\u00fcrebiliyordu.<\/p>

\"\"<\/a><\/div>\n

Londra\u2019daki St George\u2019s Hastanesi\u2019nde kalp yetmezli\u011fi hem\u015firesi olarak g\u00f6rev yapan Matthew Sunter, \u201cKalp yetmezli\u011fi sessiz bir katil. Bu tedavi y\u00f6ntemi, hayat\u0131m boyunca g\u00f6rece\u011fimi d\u00fc\u015f\u00fcnmedi\u011fim bir devrim niteli\u011finde. Pek \u00e7ok hayat kurtaracak ve bir\u00e7ok aileye umut olacak,\u201d dedi.<\/p>\n

Swansea’daki Morriston Hastanesi de yeni tedavi y\u00f6ntemini uygulamaya ba\u015flayan sa\u011fl\u0131k kurulu\u015flar\u0131 aras\u0131nda yer al\u0131yor. Burada bu y\u0131l 500 hasta bu y\u00f6ntemle tedavi edilecek.<\/p>\n

Etki ve uygulama alan\u0131<\/strong><\/h4>\n

St George\u2019s Hastanesi\u2019nde bu y\u00f6ntemle 14 hasta tedavi edildi ve y\u0131l i\u00e7inde bu say\u0131n\u0131n 100\u2019e \u00e7\u0131kar\u0131lmas\u0131 hedefleniyor. NHS \u0130ngiltere Ulusal Kalp Hastal\u0131klar\u0131 Klinik Direkt\u00f6r\u00fc Prof. Simon Roy, \u201cBu tedavi, kalp yetmezli\u011finden etkilenen binlerce insan i\u00e7in sa\u011fl\u0131k a\u00e7\u0131s\u0131ndan devrim niteli\u011finde bir geli\u015fme olabilir,\u201d dedi.<\/p>\n

Ancak uzmanlar, her hastan\u0131n bu yo\u011fun tedaviyi tolere edemeyebilece\u011fine dikkat \u00e7ekiyor. Morriston Hastanesi\u2019nden kardiyoloji uzman\u0131 Dr. Parin Shah, tedaviye ba\u015flamadan \u00f6nce hastalar\u0131n kan bas\u0131nc\u0131 ve b\u00f6brek fonksiyonlar\u0131n\u0131n detayl\u0131 \u015fekilde de\u011ferlendirildi\u011fini belirtti.<\/p>\n

Uzmanlardan destek ve h\u00fck\u00fcmetten \u00f6vg\u00fc<\/strong><\/h4>\n

British Heart Foundation\u2019dan k\u0131demli hem\u015fire Emily McGrath da y\u00f6ntemin \u201cson derece umut verici\u201d oldu\u011funu belirtti.<\/p>\n

Birle\u015fik Krall\u0131k Sa\u011fl\u0131k ve Sosyal Bak\u0131m Bakanl\u0131\u011f\u0131\u2019ndan bir s\u00f6zc\u00fc ise yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, \u201cSt George\u2019s Hastanesi\u2019ndeki ekibin bu ola\u011fan\u00fcst\u00fc ba\u015far\u0131s\u0131n\u0131 takdir ediyoruz. Bu geli\u015fme, NHS\u2019nin k\u00fcresel t\u0131p inovasyonunun \u00f6n saflar\u0131nda yer ald\u0131\u011f\u0131n\u0131 g\u00f6steriyor,\u201d ifadelerini kulland\u0131.<\/p>\n

Kalp yetmezli\u011fi, Birle\u015fik Krall\u0131k\u2019ta yakla\u015f\u0131k 1 milyon ki\u015fiyi etkiliyor ve hastal\u0131\u011f\u0131n kesin bir tedavisi bulunmuyor. Yeni uygulama sayesinde, hastalar hem daha erken d\u00f6nemde etkili tedaviye ula\u015f\u0131yor hem de hastaneye tekrar yatma riski azalt\u0131l\u0131yor.<\/p>\n

\"\"<\/a><\/div>","protected":false},"excerpt":{"rendered":"

Birle\u015fik Krall\u0131k’ta baz\u0131 hastaneler, kalp yetmezli\u011fi tedavisinde \u00e7\u0131\u011f\u0131r a\u00e7an bir uygulamaya ge\u00e7ti. Bu yeni y\u00f6ntemde hastalara, tedavinin ilk haftalar\u0131nda daha y\u00fcksek dozda ila\u00e7 veriliyor. Uygulama, \u00f6l\u00fcmleri y\u00fczde 62 oran\u0131nda azaltmas\u0131 nedeniyle uzmanlar taraf\u0131ndan \u201coyun de\u011fi\u015ftirici\u201d olarak nitelendiriliyor. The Guardian\u2019\u0131n aktard\u0131\u011f\u0131na g\u00f6re, k\u00fcresel Strong-HF adl\u0131 klinik \u00e7al\u0131\u015fmadan elde edilen veriler, tedaviye y\u00fcksek dozla ba\u015flanmas\u0131n\u0131n hem \u00f6l\u00fcm riskini hem de tekrar hastaneye yat\u0131\u015f ihtimalini \u00f6nemli \u00f6l\u00e7\u00fcde azaltt\u0131\u011f\u0131n\u0131 g\u00f6sterdi. \u00c7al\u0131\u015fma, 14 \u00fclkede 87 hastanede uyguland\u0131 ve sonu\u00e7lar\u0131 umut verici bulundu. Yeni y\u00f6ntem: H\u0131zl\u0131 doz art\u0131r\u0131m\u0131 “Rapid titration” (h\u0131zl\u0131 doz art\u0131r\u0131m\u0131) olarak bilinen y\u00f6ntemde, hastalara te\u015fhisten sonraki ilk iki hafta i\u00e7inde hedeflenen ila\u00e7 dozlar\u0131 […]<\/p>\n","protected":false},"author":1,"featured_media":5068,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[5269],"tags":[],"class_list":["post-30828","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-birlesik-krallik"],"_links":{"self":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/30828","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/comments?post=30828"}],"version-history":[{"count":0,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/30828\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/media\/5068"}],"wp:attachment":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/media?parent=30828"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/categories?post=30828"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/tags?post=30828"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}